Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soheil Meshinchi

Showing results (61-70 of 218) with videos related to

Pageof 22
Sort By:
Nature Communications|May 7, 2026
CD84 is a specific target for acute myeloid leukemia CAR-T cell therapyMartina Pigazzi, Silvia Merlini, Ambra Da Ros, et al.
Blood|March 16, 2006
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group, Richard Aplenc, Todd A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Michael Loken, Robert B Gerbing, et al.
Haematologica|December 30, 2020
Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesisThomas Milan, Magalie Celton, Karine Lagacé, et al.
Blood Advances|September 24, 2021
Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AMLLinus Angenendt, Marius Wöste, Jan-Henrik Mikesch, et al.
Plos One|September 24, 2015
Transcriptome Profiling of Pediatric Core Binding Factor AMLChih-Hao Hsu, Cu Nguyen, Chunhua Yan, et al.
Pediatric Blood & Cancer|October 16, 2013
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupAndrew S Moore, Todd A Alonzo, Robert B Gerbing, et al.
Life Science Alliance|August 27, 2024
Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoderAlice Driessen, Susanne Unger, An-Phi Nguyen, et al.
Nature Communications|November 23, 2022
Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomesHamid Bolouri, Rhonda E Ries, Alice E Wiedeman, et al.
Ejhaem|February 26, 2024
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patientsNaveen Pemmaraju, Branko Cuglievan, Joseph Lasky, et al.
Pageof 22

Showing results (61-70 of 218) with videos related to

Sort By:
Pageof 22
Nature Communications|May 7, 2026
CD84 is a specific target for acute myeloid leukemia CAR-T cell therapyMartina Pigazzi, Silvia Merlini, Ambra Da Ros, et al.
Blood|March 16, 2006
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group, Richard Aplenc, Todd A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531Jessica A Pollard, Michael Loken, Robert B Gerbing, et al.
Haematologica|December 30, 2020
Epigenetic changes in human model KMT2A leukemias highlight early events during leukemogenesisThomas Milan, Magalie Celton, Karine Lagacé, et al.
Blood Advances|September 24, 2021
Calcitonin receptor-like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AMLLinus Angenendt, Marius Wöste, Jan-Henrik Mikesch, et al.
Plos One|September 24, 2015
Transcriptome Profiling of Pediatric Core Binding Factor AMLChih-Hao Hsu, Cu Nguyen, Chunhua Yan, et al.
Pediatric Blood & Cancer|October 16, 2013
BIRC5 (survivin) splice variant expression correlates with refractory disease and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology GroupAndrew S Moore, Todd A Alonzo, Robert B Gerbing, et al.
Life Science Alliance|August 27, 2024
Identification of single-cell blasts in pediatric acute myeloid leukemia using an autoencoderAlice Driessen, Susanne Unger, An-Phi Nguyen, et al.
Nature Communications|November 23, 2022
Inflammatory bone marrow signaling in pediatric acute myeloid leukemia distinguishes patients with poor outcomesHamid Bolouri, Rhonda E Ries, Alice E Wiedeman, et al.
Ejhaem|February 26, 2024
Efficacy and manageable safety of tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a case series of pediatric and adolescent/young adult patientsNaveen Pemmaraju, Branko Cuglievan, Joseph Lasky, et al.
Pageof 22